ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.
As we approach the Convergence Age, the physical, digital, and biological are merging into a hyperconnected environment. Our ...
As NEET UG 2026 approaches, lakhs of aspirants prepare for one of India’s most competitive exams, where over 22 lakh students ...